Kimiko Yurugi

Summary

Affiliation: Kyoto University
Country: Japan

Publications

  1. pmc AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model
    H Yao
    Blood Cancer J 1:e43. 2011
  2. ncbi request reprint Future prospect of RNA interference for cancer therapies
    Eishi Ashihara
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Shogoin Sakyo ku, Kyoto, 606 8507, Japan
    Curr Drug Targets 11:345-60. 2010
  3. ncbi request reprint Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival
    Eishi Ashihara
    Department of Blood Transfusion and Cell Therapy, Kyoto, Japan
    Transplantation 83:506-9. 2007
  4. doi request reprint beta-catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model
    Eishi Ashihara
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto University Hospital, Kyoto, Japan
    Clin Cancer Res 15:2731-8. 2009
  5. ncbi request reprint Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center
    Takeshi Yuasa
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto, Japan
    Transfusion 45:879-84. 2005
  6. ncbi request reprint Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?
    Tomohide Hori
    Department of Transplant Surgery, Kyoto University Hospital, Kyoto, Japan
    Surgery 147:840-4. 2010
  7. doi request reprint Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts
    Aya Miyagawa-Hayashino
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Liver Transpl 18:1333-42. 2012
  8. ncbi request reprint Incidence and pattern of hemolytic anemia after minor ABO-mismatched living-donor lobar lung transplantation
    Akihiro Ohsumi
    Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    Surg Today 43:1250-3. 2013
  9. doi request reprint Redo living-donor lobar lung transplantation for bronchiolitis obliterans associated with antibody-mediated rejection
    Fengshi Chen
    Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Transpl Int 27:e8-12. 2014
  10. ncbi request reprint Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantation
    Takeshi Yuasa
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto, Japan
    Hum Immunol 66:295-300. 2005

Collaborators

Detail Information

Publications19

  1. pmc AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model
    H Yao
    Blood Cancer J 1:e43. 2011
    ..This study also illustrates the potential of high-throughput transcriptional screening to identify candidates for anticancer drug discovery...
  2. ncbi request reprint Future prospect of RNA interference for cancer therapies
    Eishi Ashihara
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Shogoin Sakyo ku, Kyoto, 606 8507, Japan
    Curr Drug Targets 11:345-60. 2010
    ..Results of current studies and clinical trials demonstrate that manipulation of RNAi mechanism by use of targeted siRNA offers promising strategies for cancer therapies...
  3. ncbi request reprint Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival
    Eishi Ashihara
    Department of Blood Transfusion and Cell Therapy, Kyoto, Japan
    Transplantation 83:506-9. 2007
    ..5%; negative group, 81.9%; P=3.3x10). We conclude that antidonor antibodies have adverse effects on the clinical outcome of LDLTs, and that being female and/or older aged (>or=18 years of age) are risk factors for LDLT...
  4. doi request reprint beta-catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model
    Eishi Ashihara
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto University Hospital, Kyoto, Japan
    Clin Cancer Res 15:2731-8. 2009
    ..beta-catenin overexpression correlates positively with prognosis in several types of malignancies. We herein assessed its effects on growth of multiple myeloma cells using a xenograft model...
  5. ncbi request reprint Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center
    Takeshi Yuasa
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto, Japan
    Transfusion 45:879-84. 2005
    ....
  6. ncbi request reprint Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?
    Tomohide Hori
    Department of Transplant Surgery, Kyoto University Hospital, Kyoto, Japan
    Surgery 147:840-4. 2010
    ..There is still no consensus on the importance of lymphocyte cross-matching (LCM) in the field of living-donor liver transplantation (LDLT)...
  7. doi request reprint Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts
    Aya Miyagawa-Hayashino
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Liver Transpl 18:1333-42. 2012
    ....
  8. ncbi request reprint Incidence and pattern of hemolytic anemia after minor ABO-mismatched living-donor lobar lung transplantation
    Akihiro Ohsumi
    Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    Surg Today 43:1250-3. 2013
    ..Solid organ transplants from donors with minor ABO-mismatches can be complicated by hemolysis. We investigated the incidence of de novo anti-ABO antibody production and hemolysis in patients receiving LDLLT across minor ABO-mismatches...
  9. doi request reprint Redo living-donor lobar lung transplantation for bronchiolitis obliterans associated with antibody-mediated rejection
    Fengshi Chen
    Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Transpl Int 27:e8-12. 2014
    ..Herein, we report this rare case and compare the clinical course and pathological findings...
  10. ncbi request reprint Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantation
    Takeshi Yuasa
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto, Japan
    Hum Immunol 66:295-300. 2005
    ..We speculate that a gene at the locus close to HLA plays an important role in the pathogenesis of BA...
  11. doi request reprint Antibody-mediated rejection of a unilateral donor lung in bilateral living-donor lobar lung transplantation: report of a case
    Fengshi Chen
    Department of Thoracic Surgery, Kyoto University, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    Surg Today 42:808-11. 2012
    ..Fortunately, we could perform direct crossmatch even 1 year after lung transplantation because of the living donors...
  12. ncbi request reprint B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation
    Hiroto Egawa
    Department of Surgery, Faculty of Medicine, Kyoto University, Kyoto, Japan
    Liver Transpl 13:579-88. 2007
    ....
  13. pmc Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan
    Tomohide Hori
    Department of Hepato Pancreato Biliary, Kyoto University Hospital, Kyoto 606 8507, Japan
    World J Gastroenterol 17:1848-57. 2011
    ..To investigate thrombotic microangiopathy (TMA) in liver transplantion, because TMA is an infrequent but life-threatening complication in the transplantation field...
  14. doi request reprint Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation
    Adeeb Salah
    Departments of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Liver Transpl 20:200-9. 2014
    ..C4d positivity is common among ABO-I patients and may not be associated with allograft dysfunction if alloantibody titers are not elevated...
  15. ncbi request reprint [Detection of antibodies specific for blood group antigens A and B]
    Kimiko Yurugi
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto 606 8507
    Rinsho Byori 53:1011-8. 2005
    ..Therefore, we have developed a method based on surface plasmon resonance (SPR) that detects the presence of the antigen-antibody complex without any labeling. This method allows us to rapidly quantitate anti-A/B IgG Ab levels...
  16. ncbi request reprint Rapid quantitation of immunoglobulin G antibodies specific for blood group antigens A and B by surface plasmon resonance
    Shinya Kimura
    Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kawahara cho Shogoin, Sakyo ku, Kyoto, Japan
    Transfusion 45:56-62. 2005
    ..Currently existing methods to detect IgG anti-A/B suffer limitations owing to high costs, low throughput, and poor adaptability to automation...
  17. doi request reprint A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders
    Noriyuki Yamakawa
    From the Department of Rheumatology and Clinical Immunology, The Department of Diagnostic Pathology, the Center for Genomic Medicine, and the Department of Hematology and Oncology, Kyoto University Graduate School of Medicine the Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital the HLA Foundation Laboratory, Kyoto, Japan
    J Rheumatol 41:293-9. 2014
    ..The aim of our study was to clarify the clinical, histological, and genetic factors that predict outcomes in patients with MTX-LPD...
  18. pmc ACPA-negative RA consists of two genetically distinct subsets based on RF positivity in Japanese
    Chikashi Terao
    Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    PLoS ONE 7:e40067. 2012
    ..ACPA-negative RF-positive RA is strongly associated with HLA-DRB1*04:05 and *09:01. ACPA-negative RF-negative RA is associated with DR14 and the HLA-DR8 homozygote...
  19. doi request reprint ABO-incompatible living-donor lobar lung transplantation
    Tsuyoshi Shoji
    Department of Thoracic Surgery, Kyoto University, 54 Shogoin Kawahara cho, Kyoto, Japan
    J Heart Lung Transplant 30:479-80. 2011
    ..To our knowledge, this case represents the first successful living-donor lobar lung transplantation from ABO-incompatible donors...